How biotech startups are funded, from seed round to IPO
Grants, angels, venture rounds, partnerships, IPOs and the less familiar routes in between, and what each one costs a founder in ownership.
The Science desk
Every explainer and research read we have published, newest first: stem cells and tissue repair, how biotech medicines are made and tested, clinical trials, careers and the business side of the life sciences. 15 pieces so far.
What blood stem cell donors actually go through
From cheek swab to donation day and the year after: what registry donors go through, the two ways to donate, recovery, costs and contact with the patient.
Cord blood, genetic diversity and the search for a match
Why patients of mixed or non-European ancestry face longer odds of a matched adult donor, and how cord blood and half-matched transplants changed that.
Moving from the bench to the business side of biotech
Eight business roles that hire former lab scientists, what each borrows from bench work, and how people make the switch without losing years.
Talking about stem cells in the classroom, with activities and discussion questions
A practical guide for teachers and curious students on stem cell science and ethics, with activities, discussion questions and sources worth trusting.
CAR-T cell therapy in plain language, from collection day to the months after
What CAR-T cell therapy is, what happens from cell collection to infusion and recovery, its main side effects, costs, and where trials are heading next.
Organoids, the mini-organs in a dish: questions and answers
What organoids are, how they are grown, what gut, brain, kidney and tumor organoids are used for, where they fall short and how the rules are changing.
Induced pluripotent stem cells explained: how adult cells are wound back to the start
How four genes turned adult cells into pluripotent stem cells, what iPSCs are used for, the first patients treated and the safety questions still open.
Why most drugs fail between phase 2 and approval
Phase 2 is where most experimental drugs stop. The numbers behind that, the main reasons, and what they mean when you read trial news.
Skin aging: what the evidence supports, and what it does not
How skin ages from the inside and the outside, and how strong the evidence really is for sunscreen, retinoids, vitamin C, lifestyle and stem cell creams.
Unproven stem cell clinics: why they spread and the warning signs
What unproven stem cell clinics sell, the harms and FDA actions on record, plus warning signs and questions to ask before paying for a treatment.
A day in a cell therapy manufacturing lab, hour by hour
A composite shift in a GMP cell therapy facility, from gowning at dawn to handover at dusk, plus who works there and how they got the job.